LCDX logo

Caliber Imaging & Diagnostics, Inc. Stock Price

OTCPK:LCDX Community·US$3.4k Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

LCDX Share Price Performance

US$0.0005
0.00 (150.00%)
US$0.0005
0.00 (150.00%)
Price US$0.0005

LCDX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Low risk with weak fundamentals.

3 Risks
0 Rewards

Caliber Imaging & Diagnostics, Inc. Key Details

US$3.1m

Revenue

US$2.7m

Cost of Revenue

US$486.0k

Gross Profit

US$6.7m

Other Expenses

-US$6.2m

Earnings

Last Reported Earnings
Mar 31, 2014
Next Reporting Earnings
n/a
0
0%
0%
0%
View Full Analysis

About LCDX

Founded
1991
Employees
n/a
CEO
L. Hone
WebsiteView website
www.caliberid.com

Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.

Recent LCDX News & Updates

No updates

Recent updates

No updates